13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001697013
申报总市值
US$19.3亿
US$19.3亿
74 檔
28.6%
在 Q2 2024 申报期间，Eversept Partners, LP（CIK: 0001697013）向美国 SEC 提交的 Form 13F 报告显示，其追踪之股票投资组合总市值达 US$19.3亿，共持有 74 个公开申报仓位。
Eversept Partners, LP 在 Q2 2024 进行了结构性的板块轮动与仓位换股。在开立 11 个全新仓位及加仓 12 档持股的同时，亦同步清仓 9 档并减仓 18 档标的。
在资产配置集中度方面，Eversept Partners, LP 的前 5 大核心持股（包含 QQQ, GSK, NTRA 等）合计占整体申报市值的 28.6%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | QQQ | Invesco Qqq Trust Series 1 | ETF-科技型 | 9.37% | -3.49% | -12.61% | |
| 2 | GSK | Gsk Plc-spon Adr | 股票-医疗保健 | 9.14% | -3.89% | -8.06% | |
| 3 | NTRA | Natera Inc | 股票-医疗保健 | 8.70% | -1.58% | -34.00% | |
| 4 | INSM | Insmed Inc | 股票-医疗保健 | 5.30% | +0.55% | — | |
| 5 | TEVA | Teva Pharmaceutical-sp Adr | 股票-医疗保健 | 5.25% | — | -21.65% | |
| 6 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 5.13% | -0.17% | -6.29% | |
| 7 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 5.08% | -0.38% | +15.34% | |
| 8 | VERA | Vera Therapeutics Inc | 股票-其他 | 5.06% | +0.32% | +12.03% | |
| 9 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 4.88% | — | +26.70% | |
| 10 | RVTY | Revvity Inc | 股票-医疗保健 | 3.24% | +0.09% | -6.54% | |
| 11 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 2.98% | +0.01% | +30.49% | |
| 12 | TECH | Bio-techne CORP | 股票-医疗保健 | 2.66% | -0.28% | -10.64% | |
| 13 | HQY | Healthequity Inc | 股票-医疗保健 | 2.44% | -0.23% | EXIT | |
| 14 | CYH | Community Health Systems Inc | 股票-其他 | 1.85% | +0.01% | +0.71% | |
| 15 | RGEN | Repligen CORP | 股票-医疗保健 | 1.68% | -0.65% | +2258.76% | |
| 16 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.60% | +0.46% | -10.98% | |
| 17 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 1.49% | +0.23% | +21.37% | |
| 18 | NVO | Novo-nordisk A/s-spons Adr | 股票-医疗保健 | 1.44% | +0.42% | NEW | |
| 19 | LLY | Eli Lilly & Co | 股票-医疗保健 | 1.32% | +0.33% | +64.89% | |
| 20 | PTGX | Protagonist Therapeutics Inc | 股票-其他 | 1.20% | +0.37% | NEW | |
| 21 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股与成长 | 1.15% | -3.67% | EXIT | |
| 22 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 1.02% | — | -36.55% | |
| 23 | HUM | Humana Inc | 股票-医疗保健 | 0.97% | +0.64% | NEW | |
| 24 | VTRS | Viatris Inc | 股票-医疗保健 | 0.97% | — | +0.97% | |
| 25 | ZIMV | Zimvie Inc | 股票-其他 | 0.96% | — | +35.99% | |
| 26 | MNKD | Mannkind CORP | 股票-其他 | 0.81% | — | -5.61% | |
| 27 | BKD | Brookdale Senior Living Inc | 股票-其他 | 0.72% | +0.27% | +17.29% | |
| 28 | DHR | Danaher CORP | 股票-医疗保健 | 0.70% | — | — | |
| 29 | XBI | Ss Spdr S&p Biotech ETF | ETF-科技型 | 0.63% | +0.05% | — | |
| 30 | TVTX | Travere Therapeutics Inc | 股票-其他 | 0.61% | +1.50% | +14.18% | |
| 31 | ELV | Elevance Health Inc | 股票-医疗保健 | 0.54% | — | +1.83% | |
| 32 | ARQT | Arcutis Biotherapeutics Inc | 股票-其他 | 0.53% | -0.54% | — | |
| 33 | CNC | Centene CORP | 股票-医疗保健 | 0.53% | -0.19% | EXIT | |
| 34 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 0.51% | +0.05% | +299.43% | |
| 35 | VKTX | Viking Therapeutics Inc | 股票-医疗保健 | 0.50% | +0.81% | +506.93% | |
| 36 | PCVX | Vaxcyte Inc | 股票-其他 | 0.50% | -0.93% | -51.31% | |
| 37 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 0.49% | -0.56% | -19.54% | |
| 38 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 0.47% | — | — | |
| 39 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 0.43% | — | -6.80% | |
| 40 | EOLS | Evolus Inc | 股票-其他 | 0.43% | — | — | |
| 41 | MOH | Molina Healthcare Inc | 股票-医疗保健 | 0.37% | +0.73% | +213.61% | |
| 42 | STRO | Sutro Biopharma, Inc. | 股票-其他 | 0.35% | — | +59.35% | |
| 43 | GOSS | Gossamer Bio Inc | 股票-其他 | 0.34% | — | -8.51% | |
| 44 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 0.34% | — | — | |
| 45 | CERE1EUR | Cerevel Therapeutics Holding | 股票-其他 | 0.31% | — | — | |
| 46 | LQDA | Liquidia CORP | 股票-其他 | 0.31% | +0.42% | -5.71% | |
| 47 | MYGN | Myriad Genetics Inc | 股票-其他 | 0.30% | — | — | |
| 48 | PBYI | Puma Biotechnology Inc | 股票-其他 | 0.30% | — | -6.87% | |
| 49 | KPTIEUR | Karyopharm Therapeutics Inc | 股票-其他 | 0.30% | — | -0.58% | |
| 50 | TSVT* | 2seventy Bio Inc | 股票-其他 | 0.29% | — | -5.94% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | INSM | Insmed Inc | +5.3% | NEW | 新建仓 |
| 2 | RGEN | Repligen CORP | +1.6% | +2258.76% | 加仓 |
| 3 | UTHR | United Therapeutics CORP | +1.3% | -6.29% | 减仓 |
| 4 | NVO | Novo-nordisk A/s-spons Adr | +0.9% | +135.72% | 加仓 |
| 5 | HCA | Hca Healthcare Inc | +0.7% | +30.49% | 加仓 |
| 6 | LLY | Eli Lilly & Co | +0.7% | +64.89% | 加仓 |
| 7 | XBI | Ss Spdr S&p Biotech ETF | +0.6% | NEW | 新建仓 |
| 8 | ARQT | Arcutis Biotherapeutics Inc | +0.5% | NEW | 新建仓 |
| 9 | CYTK | Cytokinetics Inc | +0.5% | NEW | 新建仓 |
| 10 | EOLS | Evolus Inc | +0.4% | NEW | 新建仓 |
| 11 | PTGX | Protagonist Therapeutics Inc | +0.4% | +22.93% | 加仓 |
| 12 | IONS | Ionis Pharmaceuticals Inc | +0.4% | +21.37% | 加仓 |
| 13 | VKTX | Viking Therapeutics Inc | +0.4% | +506.93% | 加仓 |
| 14 | OSCR | Oscar Health Inc - Class A | +0.3% | NEW | 新建仓 |
| 15 | VRDN | Viridian Therapeutics Inc | +0.3% | +299.43% | 加仓 |
| 16 | ZIMV | Zimvie Inc | +0.3% | +35.99% | 加仓 |
| 17 | CERE1EUR | Cerevel Therapeutics Holding | +0.3% | NEW | 新建仓 |
| 18 | MYGN | Myriad Genetics Inc | +0.3% | NEW | 新建仓 |
| 19 | MLTX | Moonlake Immunotherapeutics | +0.2% | NEW | 新建仓 |
| 20 | MOH | Molina Healthcare Inc | +0.2% | +213.61% | 加仓 |
| 21 | TRML | Tourmaline Bio Inc | +0.2% | NEW | 新建仓 |
| 22 | AUTL | Autolus Therapeutics PLC | +0.2% | NEW | 新建仓 |
| 23 | GOSS | Gossamer Bio Inc | -0.1% | -8.51% | 减仓 |
| 24 | TSVT* | 2seventy Bio Inc | -0.1% | -5.94% | 减仓 |
| 25 | RVTY | Revvity Inc | -0.1% | -6.54% | 减仓 |
| 26 | ✓ | Amarin Corp PLC | -0.2% | -30.65% | 减仓 |
| 27 | VERA | Vera Therapeutics Inc | -0.2% | +12.03% | 加仓 |
| 28 | TECH | Bio-techne CORP | -0.2% | -10.64% | 减仓 |
| 29 | PBYI | Puma Biotechnology Inc | -0.2% | -6.87% | 减仓 |
| 30 | STOK | Stoke Therapeutics Inc | -0.2% | -78.87% | 减仓 |
| 31 | MOR2 | Morphosys AG Adr | -0.2% | EXIT | 清仓 |
| 32 | KPTIEUR | Karyopharm Therapeutics Inc | -0.2% | -0.58% | 减仓 |
| 33 | KRYS | Krystal Biotech Inc | -0.2% | EXIT | 清仓 |
| 34 | CRBP | Corbus Pharmaceuticals Holdi | -0.2% | EXIT | 清仓 |
| 35 | QQQ | Invesco Qqq Trust Series 1 | -0.3% | -12.61% | 减仓 |
| 36 | WAT | Waters CORP | -0.3% | EXIT | 清仓 |
| 37 | IMVT | Immunovant Inc | -0.4% | -63.64% | 减仓 |
| 38 | CLDX | Celldex Therapeutics Inc | -0.4% | -10.98% | 减仓 |
| 39 | PCVX | Vaxcyte Inc | -0.4% | -51.31% | 减仓 |
| 40 | ARGX | Argenx Se - Adr | -0.4% | -36.55% | 减仓 |
| 41 | TEVA | Teva Pharmaceutical-sp Adr | -0.4% | -21.65% | 减仓 |
| 42 | GH | Guardant Health Inc | -0.4% | -77.90% | 减仓 |
| 43 | TSHA | Taysha Gene Therapies Inc | -0.5% | EXIT | 清仓 |
| 44 | ✓ | Taro Pharmaceutical Inds LTD | -0.7% | EXIT | 清仓 |
| 45 | INSP | Inspire Medical Systems Inc | -1.2% | +26.70% | 加仓 |
| 46 | THC | Tenet Healthcare CORP | -1.2% | EXIT | 清仓 |
| 47 | GSK | Gsk Plc-spon Adr | -1.7% | -8.06% | 减仓 |
| 48 | SWAVUSD | Shockwave Medical Inc | -1.8% | EXIT | 清仓 |
| 49 | PFE | Pfizer Inc | -2% | EXIT | 清仓 |
| 50 | NTRA | Natera Inc | -2.2% | -34.00% | 减仓 |
根据 SEC 官方 Form 13F 申报备案，Eversept Partners, LP 在 Q2 2024 季度的美股持仓总市值约为 US$19.3亿，共申报了 74 个公开持股仓位。
在 Q2 2024 季度，Eversept Partners, LP 按市值排列的前三大核心持股分别为：QQQ (9.4%)、GSK (9.1%)、NTRA (8.7%)。其中最大持股仓位 QQQ 占据整体投资组合约 9.4% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
INSM
市值: US$7742.4万
本季最大获利了结 / 清仓标的
PFE
前期市值: US$3058.2万
在 Q2 2024 季度中，Eversept Partners, LP 共进行了 50 项持仓异动，包含新建仓 11 个仓位、加仓 12 个仓位、减仓 18 个仓位以及清仓 9 个仓位。 其中最大新建仓标的为 INSM。 本季清仓仓位包含 PFE。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。